Investing
The 52-Week Low Club
February 9, 2009 4:28 pm
Last Updated: March 23, 2020 12:50 pm
ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16.
Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25.
Popular Inc (BPOP) Concerns bank could fail.
Douglas A. McIntyre
Editors' Picks
